NICE issues guidelines on familial breast cancer

18 May 2005

The National Institute of Clinical Excellence (NICE) and the National Collaborating Centre for Primary Care (NCCPC) have today released a set of guidelines relating to the classification and care of women at risk of familial breast cancer. The guidance states that women calculated to have a low risk of developing breast cancer (lifetime risk of less than 17%) should normally be cared for in primary care; those found to have a moderate level of risk (lifetime risk of 17-30%) should generally be cared for in secondary care, and those at high risk should receive tertiary level care. High risk is defined as a calculated lifetime risk of 30% or greater, or a 20% or greater chance of a faulty BRCA1, BRCA2 or TP53 gene in the family. Protocols for the management of women at each level of care are set out in the guidelines.

It is proposed that women

More from us

Genomics and policy news